SPANU, DARIO
 Distribuzione geografica
Continente #
EU - Europa 6.376
NA - Nord America 270
AS - Asia 107
OC - Oceania 2
Totale 6.755
Nazione #
IT - Italia 6.274
US - Stati Uniti d'America 265
SE - Svezia 45
CN - Cina 42
SG - Singapore 20
IN - India 16
NL - Olanda 13
FI - Finlandia 9
GB - Regno Unito 8
KR - Corea 8
FR - Francia 6
BE - Belgio 5
DE - Germania 5
HK - Hong Kong 5
CA - Canada 4
IE - Irlanda 4
TH - Thailandia 4
VN - Vietnam 4
GR - Grecia 3
IR - Iran 3
JP - Giappone 3
AT - Austria 2
AU - Australia 2
CZ - Repubblica Ceca 1
ES - Italia 1
IL - Israele 1
TR - Turchia 1
TT - Trinidad e Tobago 1
Totale 6.755
Città #
Cagliari 6.214
Chandler 45
Nyköping 41
Fairfield 33
Ashburn 23
Boardman 23
Rome 20
New York 17
Shanghai 16
Seattle 12
Amsterdam 11
Houston 11
Pune 11
Helsinki 9
San Diego 9
Seoul 8
Wilmington 8
Singapore 7
Woodbridge 7
Boston 6
Cambridge 6
Menlo Park 5
Dong Ket 4
La Maddalena 4
Paris 4
Toronto 4
Peristeri 3
Sassari 3
Delhi 2
Don Mueang 2
Dublin 2
Enna 2
Godo 2
Guangzhou 2
Hefei 2
Hong Kong 2
Islington 2
Jinhua 2
Leuven 2
Livorno 2
Los Angeles 2
Molenbeek-Saint-Jean 2
Nakano 2
Naples 2
Romainville 2
San Francisco 2
Shenzhen 2
Sydney 2
Turin 2
Vienna 2
Xian 2
Alexandria 1
Amgaon 1
Ankara 1
Beijing 1
Bilbao 1
Brno 1
Brussels 1
Chandigarh 1
Clifton 1
Ebisu 1
Exeter 1
Frankfurt am Main 1
Frattamaggiore 1
Gela 1
Heidelberg 1
Hounslow 1
Jacksonville 1
Jiaxing 1
Jinan 1
London 1
Miami Beach 1
Milan 1
Munich 1
Naaldwijk 1
Nanjing 1
New Bedfont 1
Olbia 1
Port-of-spain 1
Pozzuoli 1
Rockville 1
Sambuca di Sicilia 1
San Mateo 1
South Deerfield 1
Stockholm 1
Tabriz 1
Washington 1
Wuhan 1
Wuxi 1
Totale 6.648
Nome #
Molecular-biology-driven treatment for metastatic colorectal cancer 2.156
Introducing immunotherapy for advanced hepatocellular carcinoma patients: Too early or too fast? 627
How to improve metastatic pancreatic ductal adenocarcinoma patients' selection: Between clinical trials and the real-world 495
Molecular-driven treatment for biliary tract cancer: the promising turning point 484
CDX-2 expression correlates with clinical outcomes in MSI-H metastatic colorectal cancer patients receiving immune checkpoint inhibitors 452
Uncovering key targets of success for immunotherapy in pancreatic cancer 428
Liquid Biopsy-Driven Cetuximab Rechallenge Strategy in Molecularly Selected Metastatic Colorectal Cancer Patients 365
BRCA-mutant pancreatic ductal adenocarcinoma 359
Circulating tumour DNA in gastrointestinal cancer in clinical practice: Just a dream or maybe not? 311
Neoadjuvant chemo-radiotherapy response in patients affected by mismatch repair deficient (dMMR) locally advanced rectal cancer 301
Hepatocellular carcinoma and microbiota: Implications for clinical management and treatment 292
Mismatch repair proteins (MMR) expression as predictive factor in locally advanced rectal cancer 190
Influence of antidiabetic drugs on glucose metabolism and immune response in patients with metastatic pancreatic ductal adenocarcinoma receiving gemcitabine plus nab-paclitaxel as first-line treatment 188
Prediction of Response to Anti-Angiogenic Treatment for Advanced Colorectal Cancer Patients: From Biological Factors to Functional Imaging 86
null 47
Thyroid dysfunction and immune checkpoint inhibitors: Effect on survival in elderly patients 12
Role of neutrophil-to-lymphocyte ratio (NLR) in the outcome of NSCLC EGFR mutated 6
Totale 6.799
Categoria #
all - tutte 10.791
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.791


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021959 0 0 1 330 197 120 40 64 35 70 49 53
2021/2022892 53 48 3 25 40 78 38 73 63 79 143 249
2022/20232.566 188 345 306 175 170 191 126 215 194 321 205 130
2023/20242.244 95 66 76 119 188 389 361 159 117 156 263 255
2024/2025138 138 0 0 0 0 0 0 0 0 0 0 0
Totale 6.799